Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Tett

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Clinical Pharmacokinetics|November 1, 1993
Clinical pharmacokinetics of slow-acting antirheumatic drugsS E Tett
Clinical Pharmacology and Therapeutics|April 11, 2008
Clinical pharmacology: opportunities for educating new practitioners--an Australian perspectiveS E Tett
British Journal of Clinical Pharmacology|April 1, 1996
Enantioselective disposition of hydroxychloroquineA J McLachlan, S E Tett
Journal of Chromatography. B, Biomedical Sciences and Applications|October 29, 1998
Determination of pindolol enantiomers in human plasma and urine by simple liquid-liquid extraction and high-performance liquid chromatographyJ L Beal, S E Tett
European Journal of Clinical Pharmacology|January 1, 1987
Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling timesS E Tett, D J Cutler
Therapeutic Drug Monitoring|August 26, 1998
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approachA J McLachlan, S E Tett
Journal of Chromatography. B, Biomedical Sciences and Applications|February 23, 1999
Improved high-performance liquid chromatography determination of methotrexate and its major metabolite in plasma using a poly(styrene-divinylbenzene) columnE A McCrudden, S E Tett
British Journal of Clinical Pharmacology|April 1, 1996
Pharmacokinetics of fluconazole in people with HIV infection: a population analysisA J McLachlan, S E Tett
Drugs & Aging|December 1, 1996
Use of methotrexate in older patients. A risk-benefit assessmentS E Tett, E J Triggs
Journal of Clinical Pharmacy and Therapeutics|June 30, 2005
Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitorsK Behan, C Cutts, S E Tett
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Clinical Pharmacokinetics|November 1, 1993
Clinical pharmacokinetics of slow-acting antirheumatic drugsS E Tett
Clinical Pharmacology and Therapeutics|April 11, 2008
Clinical pharmacology: opportunities for educating new practitioners--an Australian perspectiveS E Tett
British Journal of Clinical Pharmacology|April 1, 1996
Enantioselective disposition of hydroxychloroquineA J McLachlan, S E Tett
Journal of Chromatography. B, Biomedical Sciences and Applications|October 29, 1998
Determination of pindolol enantiomers in human plasma and urine by simple liquid-liquid extraction and high-performance liquid chromatographyJ L Beal, S E Tett
European Journal of Clinical Pharmacology|January 1, 1987
Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling timesS E Tett, D J Cutler
Therapeutic Drug Monitoring|August 26, 1998
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approachA J McLachlan, S E Tett
Journal of Chromatography. B, Biomedical Sciences and Applications|February 23, 1999
Improved high-performance liquid chromatography determination of methotrexate and its major metabolite in plasma using a poly(styrene-divinylbenzene) columnE A McCrudden, S E Tett
British Journal of Clinical Pharmacology|April 1, 1996
Pharmacokinetics of fluconazole in people with HIV infection: a population analysisA J McLachlan, S E Tett
Drugs & Aging|December 1, 1996
Use of methotrexate in older patients. A risk-benefit assessmentS E Tett, E J Triggs
Journal of Clinical Pharmacy and Therapeutics|June 30, 2005
Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitorsK Behan, C Cutts, S E Tett
Pageof 5